1. Home
  2. NPWR vs ELTX Comparison

NPWR vs ELTX Comparison

Compare NPWR & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPWR
  • ELTX
  • Stock Information
  • Founded
  • NPWR 2010
  • ELTX 2011
  • Country
  • NPWR United States
  • ELTX United States
  • Employees
  • NPWR N/A
  • ELTX N/A
  • Industry
  • NPWR Industrial Machinery/Components
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NPWR Energy
  • ELTX Health Care
  • Exchange
  • NPWR Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • NPWR 148.7M
  • ELTX 121.7M
  • IPO Year
  • NPWR N/A
  • ELTX N/A
  • Fundamental
  • Price
  • NPWR $2.13
  • ELTX $7.23
  • Analyst Decision
  • NPWR Buy
  • ELTX Strong Buy
  • Analyst Count
  • NPWR 2
  • ELTX 2
  • Target Price
  • NPWR $4.00
  • ELTX $9.50
  • AVG Volume (30 Days)
  • NPWR 1.3M
  • ELTX 34.8K
  • Earning Date
  • NPWR 05-12-2025
  • ELTX 05-13-2025
  • Dividend Yield
  • NPWR N/A
  • ELTX N/A
  • EPS Growth
  • NPWR N/A
  • ELTX N/A
  • EPS
  • NPWR N/A
  • ELTX N/A
  • Revenue
  • NPWR $250,000.00
  • ELTX N/A
  • Revenue This Year
  • NPWR $308.00
  • ELTX N/A
  • Revenue Next Year
  • NPWR $1,811.08
  • ELTX N/A
  • P/E Ratio
  • NPWR N/A
  • ELTX N/A
  • Revenue Growth
  • NPWR 100.00
  • ELTX N/A
  • 52 Week Low
  • NPWR $1.48
  • ELTX $3.34
  • 52 Week High
  • NPWR $14.28
  • ELTX $9.99
  • Technical
  • Relative Strength Index (RSI)
  • NPWR 55.27
  • ELTX 64.98
  • Support Level
  • NPWR $1.48
  • ELTX $5.15
  • Resistance Level
  • NPWR $1.75
  • ELTX $7.94
  • Average True Range (ATR)
  • NPWR 0.24
  • ELTX 0.50
  • MACD
  • NPWR 0.10
  • ELTX 0.27
  • Stochastic Oscillator
  • NPWR 56.52
  • ELTX 74.55

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: